Sotac Pharmaceuticals Limited IPO
Sotac Pharmaceuticals Limited is an NSE SME IPO listed on the NSE SME platform, priced at ₹105–₹111 per share. The stock debuted at ₹115, delivering a listing gain of 3.6%. The IPO had a lot size of ₹1200 shares and a minimum investment of ₹1,33,200.
Sotac Pharmaceuticals Limited IPO
- IPO Dates
- Mar 29, 2023 – Apr 3, 2023
- Price band
- ₹105-111 per equity share
- Minimum Investment
- ₹1,33,200
- Issue size
- 3,000,000 shares(aggregating up to ₹33.30 Cr)
- Lot size
- 1200
- Allotment Date
- Apr 10, 2023
- Listing
- Apr 13, 2023
- Listing At
- NSE SME
IPO timeline
-
Mar 29, 2023
Open Date
Completed
-
Apr 3, 2023
Close Date
Completed
-
Apr 10, 2023
Allotment Date
Completed
-
Apr 13, 2023
Listing Date
Completed
Sotac Pharmaceuticals Limited IPO Subscription Details
Sotac Pharmaceuticals Limited IPO subscription status shows demand across QIB, NII, and retail categories, helping investors understand participation levels.
Last updated:Sotac Pharmaceuticals Limited IPO Essentials
Sotac Pharmaceuticals Limited IPO Details
Sotac Pharmaceuticals Limited IPO is priced at ₹105-111 per share with a total issue size of 3,000,000 shares(aggregating up to ₹33.30 Cr). The IPO has a lot size of 1200 shares and is listed on NSE SME.
- Issue price
- ₹105-111 per equity share
- Lot size
- 1200 shares
- Face value
- ₹10 Per Equity Share
- Issue size
- 3,000,000 shares(aggregating up to ₹33.30 Cr)
- Listing at
- NSE SME
- List price
- 115.0
- Listing date
- Registrar
- KFin Technologies Limited
- Lead manager
-
Beeline Capital Advisors Pvt Ltd
Sotac Pharmaceuticals Limited IPO Analytics
Sotac Pharmaceuticals Limited IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Sotac Pharmaceuticals Limited IPO Subscription Status
Sotac Pharmaceuticals Limited IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO subscription status indicates investor demand across categories.
| As on | QIB / NII | Retail | Total |
|---|---|---|---|
| Shares Offered / Reserved | 571,800 / 428,400 | 998,400 | 1,998,600 |
|
Day 1
30-03-23 06:00 PM
|
(0.00 / 0.00) x | 0.05 x | 0.02 x |
|
Day 2
31-03-23 06:00 PM
|
(0.00 / 0.72) x | 0.15 x | 0.23 x |
|
Day 3
03-04-23 06:00 PM
|
(1.00 / 4.04) x | 0.91 x | 1.60 x |
Sotac Pharmaceuticals Limited Valuations
Earnings
- EPS (Post IPO)
- ₹3.58/-
Returns
- RoNW
- 43.47%
Sotac Pharmaceuticals Limited Financials( In Lakhs)
| 30-Sept-22 | 31-Mar-22 | 31-Mar-21 | 31-Mar-20 | |
|---|---|---|---|---|
| Assets | 6,461.60 | 3,525.35 | 3,469.75 | 3,038.21 |
| Revenue | 3,994.65 | 7,337.02 | 4,894.97 | 2,882.64 |
| Profit After Tax | 46.55 | 287.86 | -236.54 | 8.75 |
Sotac Pharmaceuticals Limited Company & Offer Insights
About Sotac Pharmaceuticals Limited
Sotac Pharmaceuticals Limited is a part of the SOTAC group, based in Gujarat. The company is in the business of manufacturing pharmaceutical products for different marketers on a loan license or contract manufacturing basis. The company's business is majorly on principle to principle basis with different marketers.
SOTAC is serving over 162 corporate clients on a loan license and/or contract manufacturing basis. With their vast experience in the pharmaceutical segment, the company is growing and enlarging its scale of operations every year.
Sotac Pharmaceuticals established its manufacturing facility in the year 2017. In the year, the company's manufacturing facility was installed with the capacity to manufacture 90 Crore tables/year, and 14 Crore Capsules/year.
With a combined experience of over 59 years in the pharmaceutical manufacturing Industry of the Promoters, the company is blooming and expanding in various horizons.
Sotac Pharmaceuticals Limited IPO Issue Objectives
- •
- To Meet Working Capital Requirements
- •
- Investment in Subsidiary
- •
- Upgradation / Construction of Existing /New Building in the Existing Premises
- •
- General Corporate Purpose
- •
- To meet Public Issue Expenses
Contact Information
Frequently Asked Questions
Click any question to reveal the answer
Sotac Pharmaceuticals Limited IPO is a book-built IPO worth ₹3,000,000 shares(aggregating up to ₹33.30 Cr). The price band is ₹105–₹111 per share. The IPO opens on Mar 29, 2023 and closes on Apr 3, 2023. It will be listed on NSE SME Platform. KFin Technologies Limited is the registrar.
The price band of Sotac Pharmaceuticals Limited IPO is ₹105 to ₹111 per share.
The lot size of Sotac Pharmaceuticals Limited IPO is 1200 shares.
The minimum investment for Sotac Pharmaceuticals Limited IPO is approximately ₹1,33,200 based on the upper price band .
Sotac Pharmaceuticals Limited IPO opens on Mar 29, 2023 and closes on Apr 3, 2023.
The allotment date of Sotac Pharmaceuticals Limited IPO is Apr 10, 2023.
Sotac Pharmaceuticals Limited IPO is expected to be listed on Apr 13, 2023, on NSE SME Platform.
Sotac Pharmaceuticals Limited IPO valuation snapshot: P/E N/A, EPS ₹3.58/-, P/B N/A, RoNW 43.47%, and market cap N/A.
To apply for Sotac Pharmaceuticals Limited IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Sotac Pharmaceuticals Limited IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Sotac Pharmaceuticals Limited IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Sotac Pharmaceuticals Limited IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Sotac Pharmaceuticals Limited IPO allotment status on IPO Ji for quick and easy access.